Ref ID: 18673
Author:
A. Alastruey-Izquierdo, PhD – Dr 1, E. Mellado, PhD – Dr 1, T. Pelaez, PhD – Dr 2, J. Peman, PhD – Dr 3, S. Zapico, PhD – Dr 4, M. Alvarez, PhD – Dr 5, M. Cuenca-Estrella, PhD, MD – Dr1, FILPOP Study Group;
Author address:
1Centro Nacional de Microbiologia. ISCIII, Majadahonda. Madrid, Spain, 2Hosp. Gregorio Marañón, Madrid, Spain, 3Hosp. La Fe, Valencia, Spain, 4Hosp. de Donostia, Guipuzcoa, Spain, 5Hosp. Central de Asturias, Oviedo, Spain.
Full conference title:
52nd Annual ICAAC
Date: 9 September 2014
Abstract:
Background: A population-based survey was conducted to investigate the frequency of antifungal resistance in clinical strains of Aspergillus spp. in Spain. Methods: The study was conducted in two different periods (October 2010 and May 2011) and included all patients admitted in 27 Spanish hospitals with a positive culture of filamentous fungus from respiratory samples, paranasal sinus aspirates, blood cultures and biopsies. They were identified by classical and molecular methods. Prevalence of sibling/cryptic species was also accounted. Susceptibility testing and interpretation were performed by EUCAST methodology and breakpoints. Results: Average prevalence was 0.02/1,000 admissions. 277 Aspergillus strains were isolated. 56% of the strains were identified as A. fumigatus sensu stricto, 9% as A. flavus, 9% as A. terreus, 8% as A. tubingensis, 7.5% as A. niger, 3% as A. nidulans, and 7.5% as other species. 22 (8%) were classified as resistant to AMB, 10 (3.6 %) to ICZ, 5 (2 %) to VCZ and 8 (3 %) to PCZ. All isolates of A. fumigatus were susceptible to all drugs except for one isolate that was resistant to PCZ. Resistance to AMB was observed in isolates of A. alliaceus, A.fumigatiaffinis, A. insuetus and A. westerdijikiae, 66% of A. lentulus strains, 22 % of A. flavus and 27% of A. terreus. Species of Aspergillus section Usti were resistant to all azoles tested. Itraconazole resistance was also found in all A. lentulus and A. fumigatiaffinis and one isolate of A. tubingensis. Conclusions: 1) Average prevalences of resistant isolates in the study were low (<8%) 2) Total rate of sibling/cryptic Aspergillus species was 15% and there were species-specific differences in antifungal susceptibility 3) Resistance was more frequent (>50%) in species belonging to those sibling/cryptic species.
Abstract Number: M-321
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a